2017
DOI: 10.1016/j.biopha.2016.11.098
|View full text |Cite
|
Sign up to set email alerts
|

Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
285
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
3

Relationship

4
5

Authors

Journals

citations
Cited by 414 publications
(307 citation statements)
references
References 105 publications
3
285
0
Order By: Relevance
“…CUR is a polyphenol with both antioxidant and hydrophobic properties (Priyadarsini, 2013; Mirzaei et al, 2017), which may explain why it preferentially adsorbs to PMMA and the cell wall of C. albicans . We hypothesized that the hydrophobic nature of the molecule could drive the coated C. albicans cells to aggregate with one another, and if we consider this within the context oral delivery within saliva then there is the possibility of creating complexes of cells that minimize their interaction with the denture surface.…”
Section: Discussionmentioning
confidence: 99%
“…CUR is a polyphenol with both antioxidant and hydrophobic properties (Priyadarsini, 2013; Mirzaei et al, 2017), which may explain why it preferentially adsorbs to PMMA and the cell wall of C. albicans . We hypothesized that the hydrophobic nature of the molecule could drive the coated C. albicans cells to aggregate with one another, and if we consider this within the context oral delivery within saliva then there is the possibility of creating complexes of cells that minimize their interaction with the denture surface.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, curcumin could induce apoptosis in cancer cell line, regulation of cell cycle, and increase of chemotherapy sensitivity (Zhou et al, ). However, some studies indicated that curcumin are associated with some limitations such as low oral absorption, bio‐distribution, and systemic bioavailability which lead to does not approved it as a drug in clinical (Mirzaei, Shakeri, et al, ). To date, several studies applied various curcumin analogs and novel drug delivery systems and can to overcoming to the current limitations (Mirzaei, Shakeri, et al, ; Momtazi et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…It has been shown that dietary factors such as curcumin have suitable anti‐cancer properties (Mirzaei, Khoi, Azizi, & Goodarzi, ). These agents exert their effects via a sequence of cellular and molecular pathways such as STAT3, MAPK, PTEN, and miRNA network (Mirzaei, Shakeri, et al, ). The utilization of these agents is associated with various advantages such as their non‐toxic properties.…”
Section: Introductionmentioning
confidence: 99%
“…[2][3][4] Importantly, oral administration of CM 12 g/day exhibited little toxicity in clinical trials. 5 However, clinical applications of insoluble CM face more challenging issues, such as low dissolution rate, low bioavailability, and controlled delivery.…”
Section: Introductionmentioning
confidence: 99%